DK3405201T3 - Stabiliseret amorft calciumcarbonat til behandling af neurologiske, muskel- og infertilitetssygdomme eller tilstande - Google Patents
Stabiliseret amorft calciumcarbonat til behandling af neurologiske, muskel- og infertilitetssygdomme eller tilstande Download PDFInfo
- Publication number
- DK3405201T3 DK3405201T3 DK17741180.8T DK17741180T DK3405201T3 DK 3405201 T3 DK3405201 T3 DK 3405201T3 DK 17741180 T DK17741180 T DK 17741180T DK 3405201 T3 DK3405201 T3 DK 3405201T3
- Authority
- DK
- Denmark
- Prior art keywords
- muscular
- neurological
- treatment
- conditions
- calcium carbonate
- Prior art date
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title 2
- 229910000019 calcium carbonate Inorganic materials 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000000509 infertility Diseases 0.000 title 1
- 230000036512 infertility Effects 0.000 title 1
- 231100000535 infertility Toxicity 0.000 title 1
- 230000003387 muscular Effects 0.000 title 1
- 230000000926 neurological effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/061—Sperm cells, spermatogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0612—Germ cells sorting of gametes, e.g. according to sex or motility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Physical Education & Sports Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662279843P | 2016-01-18 | 2016-01-18 | |
| US201662279844P | 2016-01-18 | 2016-01-18 | |
| US201662279845P | 2016-01-18 | 2016-01-18 | |
| US201662376428P | 2016-08-18 | 2016-08-18 | |
| PCT/IL2017/050059 WO2017125918A1 (en) | 2016-01-18 | 2017-01-17 | Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3405201T3 true DK3405201T3 (da) | 2023-08-21 |
Family
ID=59361712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17741180.8T DK3405201T3 (da) | 2016-01-18 | 2017-01-17 | Stabiliseret amorft calciumcarbonat til behandling af neurologiske, muskel- og infertilitetssygdomme eller tilstande |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10758566B2 (da) |
| EP (2) | EP4257141A3 (da) |
| JP (2) | JP6873389B2 (da) |
| KR (1) | KR20180109941A (da) |
| CN (1) | CN108778296A (da) |
| AU (2) | AU2017208953B2 (da) |
| BR (1) | BR112018014520A2 (da) |
| CA (2) | CA3011667A1 (da) |
| DK (1) | DK3405201T3 (da) |
| ES (1) | ES2952537T3 (da) |
| IL (1) | IL260548B2 (da) |
| RU (1) | RU2757419C2 (da) |
| WO (1) | WO2017125918A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110121351A (zh) | 2016-10-25 | 2019-08-13 | 艾玛菲克有限公司 | 用于治疗白血病的无定形碳酸钙 |
| CA3144221A1 (en) * | 2019-07-23 | 2021-01-28 | Amorphical Ltd | Amorphous calcium carbonate for improving athletic performance |
| EP4117685A4 (en) * | 2020-03-11 | 2024-03-20 | Amorphical Ltd | AMORPHOUS CALCIUM CARBONATE FOR THE TREATMENT OF ACIDOSIS |
| IT202200010592A1 (it) * | 2022-05-23 | 2023-11-23 | Neilos S R L | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” |
| IT202200010583A1 (it) * | 2022-05-23 | 2023-11-23 | Neilos S R L | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757017A (en) | 1984-09-14 | 1988-07-12 | Mcw Research Foundation, Inc. | In vitro cell culture system |
| EP1048724A1 (en) * | 1999-04-27 | 2000-11-02 | Transgene S.A. | Human myoblast cell lines and their uses |
| CA2536112A1 (en) | 2003-08-20 | 2005-03-03 | Northern Sydney And Central Coast Area Health Service | Methods for enhancing embryo viability |
| EP1670902A4 (en) * | 2003-09-08 | 2008-05-07 | Univ Texas | METHOD AND COMPOSITION FOR ENHANCING IN VITRO EMBRYONIC DEVELOPMENT BY ENRICHING A CULTURE MEDIUM COMPRISING PROSTAGLANDIN OR PROSTAGLANDIN ANALOGUE |
| PL1758599T3 (pl) | 2004-05-26 | 2014-04-30 | Ben Gurion Univ Of The Negev Research And Development Authority | Kompozycja do podania doustnego zawierająca stabilny amorficzny węglan wapnia |
| US20080039531A1 (en) * | 2005-06-13 | 2008-02-14 | Alfred Stracher | Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders |
| RU2462458C2 (ru) * | 2006-02-10 | 2012-09-27 | Байомарин Ига Лимитед | Лечение миодистрофии дюшена |
| IL178495A (en) * | 2006-10-05 | 2014-12-31 | Univ Ben Gurion | Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions |
| EP2211873B1 (en) * | 2007-10-22 | 2012-08-08 | Amorphical Ltd. | Stable amorphous calcium carbonate comprising phosphorylated amino acids |
| ES2831699T3 (es) * | 2011-12-13 | 2021-06-09 | Amorphical Ltd | Un carbonato de calcio morfo para el tratamiento de la mala absorción de calcio y los trastornos metabólicos óseos |
| JP6263181B2 (ja) | 2012-08-07 | 2018-01-17 | アモーフィカル リミテッド． | 安定化させた非晶質炭酸カルシウムの製造方法 |
| EA201591152A1 (ru) * | 2013-02-11 | 2016-03-31 | Аморфикал Лтд. | Аморфный карбонат кальция для ускоренного роста костной ткани |
| EP3174828A4 (en) | 2014-07-31 | 2018-01-17 | Amorphical Ltd. | Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate |
| JP7007716B2 (ja) | 2015-06-04 | 2022-01-25 | アモーフィカル リミテッド． | ポリリン酸塩又はビスホスホネートで安定化した非晶質炭酸カルシウム |
| KR20180109940A (ko) | 2016-01-18 | 2018-10-08 | 아모피컬 리미티드 | 세포 배양 배지용 보충물로서의 안정화된 무정형 탄산칼슘 |
-
2017
- 2017-01-17 BR BR112018014520A patent/BR112018014520A2/pt active Search and Examination
- 2017-01-17 WO PCT/IL2017/050059 patent/WO2017125918A1/en active Application Filing
- 2017-01-17 EP EP23167697.4A patent/EP4257141A3/en active Pending
- 2017-01-17 IL IL260548A patent/IL260548B2/en unknown
- 2017-01-17 US US16/069,762 patent/US10758566B2/en active Active
- 2017-01-17 JP JP2018536885A patent/JP6873389B2/ja active Active
- 2017-01-17 AU AU2017208953A patent/AU2017208953B2/en active Active
- 2017-01-17 ES ES17741180T patent/ES2952537T3/es active Active
- 2017-01-17 RU RU2018129457A patent/RU2757419C2/ru active
- 2017-01-17 CA CA3011667A patent/CA3011667A1/en active Pending
- 2017-01-17 EP EP17741180.8A patent/EP3405201B1/en active Active
- 2017-01-17 DK DK17741180.8T patent/DK3405201T3/da active
- 2017-01-17 KR KR1020187023637A patent/KR20180109941A/ko unknown
- 2017-01-17 CN CN201780018159.8A patent/CN108778296A/zh active Pending
- 2017-01-17 CA CA3239809A patent/CA3239809A1/en active Pending
-
2020
- 2020-07-21 US US16/934,689 patent/US11207347B2/en active Active
-
2021
- 2021-04-01 JP JP2021062622A patent/JP7190760B2/ja active Active
-
2022
- 2022-10-14 AU AU2022252805A patent/AU2022252805A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7190760B2 (ja) | 2022-12-16 |
| JP2019501947A (ja) | 2019-01-24 |
| WO2017125918A1 (en) | 2017-07-27 |
| IL260548B2 (en) | 2024-04-01 |
| US20200345764A1 (en) | 2020-11-05 |
| AU2017208953B2 (en) | 2022-11-03 |
| JP2023029914A (ja) | 2023-03-07 |
| KR20180109941A (ko) | 2018-10-08 |
| US11207347B2 (en) | 2021-12-28 |
| RU2018129457A (ru) | 2020-02-20 |
| ES2952537T3 (es) | 2023-11-02 |
| EP3405201B1 (en) | 2023-05-17 |
| EP4257141A2 (en) | 2023-10-11 |
| AU2022252805A1 (en) | 2022-11-10 |
| EP3405201A4 (en) | 2019-06-26 |
| CA3011667A1 (en) | 2017-07-27 |
| CA3239809A1 (en) | 2017-07-27 |
| RU2757419C2 (ru) | 2021-10-15 |
| JP6873389B2 (ja) | 2021-05-19 |
| BR112018014520A2 (pt) | 2018-12-11 |
| CN108778296A (zh) | 2018-11-09 |
| EP3405201A1 (en) | 2018-11-28 |
| EP4257141A3 (en) | 2023-11-22 |
| RU2018129457A3 (da) | 2020-10-21 |
| AU2017208953A1 (en) | 2018-09-06 |
| US20190030068A1 (en) | 2019-01-31 |
| US10758566B2 (en) | 2020-09-01 |
| JP2021105026A (ja) | 2021-07-26 |
| IL260548B1 (en) | 2023-12-01 |
| IL260548A (da) | 2018-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3570844T3 (da) | Azolopyrimidin til behandlingen af kræftrelaterede lidelser | |
| DK3407889T3 (da) | Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet | |
| DK3673080T3 (da) | Antisense-oligomerer til behandling af lidelser og sygdomme | |
| DK3728271T3 (da) | Makrocykliske forbindelser til behandling af sygdomme | |
| DK3516060T3 (da) | Antisense-oligonukleotider til behandling af øjensygdom | |
| DK3143025T3 (da) | Forbindelser til behandling af spinal muskelatrofi | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3789501T3 (da) | Fremgangsmåde til diagnosticering, behandling og forebyggelse af parkinsons sygdom | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3609529T3 (da) | Rna til behandling af autoimmune sygdomme | |
| DK3405201T3 (da) | Stabiliseret amorft calciumcarbonat til behandling af neurologiske, muskel- og infertilitetssygdomme eller tilstande | |
| BR112016022976A2 (pt) | Métodos para o tratamento de hcv | |
| CL2018001502A1 (es) | Procedimiento para el tratamiento de efluente acuoso. | |
| DK3261661T3 (da) | Menotropin til behandling af infertilitet | |
| DK3439661T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| DK3532064T3 (da) | Kombinationsbehandlinger omfattende imidazopyrazinoner til behandlingen af psykiatriske og/eller kognitive lidelser | |
| DK3612208T3 (da) | Coversin til behandlingen af autoimmune sygdomme med blisterdannelse | |
| DK3478679T3 (da) | 5,7-dihydro-pyrrolo-pyridin-derivater til behandling af neurologiske og neurodegenerative sygdomme | |
| DK3097085T3 (da) | Benzoxazinonderivater til behandling af hudsygdomme | |
| DK3432895T3 (da) | Blodpladepelletlysat til anvendelse til behandling af neurologiske forstyrrelser | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| DK3506901T3 (da) | Anvendelse af kynurensyre til behandling af muskelatrofi | |
| DK3724173T3 (da) | Forbindelser til behandling af neuromuskulære lidelser | |
| DK3373931T3 (da) | Heterocykliske forbindelser til behandling af sygdom |